To view this site, you need to have Flash Player 9.0.115 or later installed. Click here to get the latest Flash player.
(NECN) - Stock in Cambridge, Massachusetts-based Vertex Pharmaceuticals hit a one year high last week. The company is out with second quarter earnings and an update on its closely watched hepatitis C drug. Vertex chairman and CEO Matt Emmens joins NECN to discuss the company.